aap Implantate Value Stock - Dividend - Research Selection
Market price: 2,76 EUR
aap Implantate Fundamental data and company key figures of the share
|Annual reports in EUR|
|Net operating cash flow||-3.675.000|
|Free cash flow||-7.456.000|
|Liabilities & Shareholders equity||19.706.000|
|Diluted shares outstanding||32.067.400|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||93.729.536,00 USD|
|Raw Data Source||IFRS in Millionen EUR|
|Stock Split||2020-10-29,1.000000/10.000000; 2019-04-23,1619.000000/1589.000000; 2005-09-12,253.000000/251.000000; 2004-07-26,159.000000/103.000000|
Description of the company
aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.